Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 10, 2018Journal of Internal Medicine

FDG‐PET/CT in the management of lymphomas: current status and future directions

View Full Paper
Ask AI
Bookmark
Share

Authors

TETarec Christoffer El‐GalalyDVDiego VillaLGLars Christian Gormsen

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

El‐Galaly et al. (2018) studied this question.

synapsesocial.com/papers/6a014eec413f0c047f2d8aafhttps://doi.org/10.1111/joim.12813
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting.1989 · 1,640 citations
  2. 2Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification2014 · 5,731 citations
  3. 3Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group2014 · 1,677 citations
  4. 4<sup>18</sup>F-FDG Avidity in Lymphoma Readdressed: A Study of 766 Patients2009 · 383 citations
  5. 5PET-CT for staging and early response: results from the Response-Adapted Therapy in Advanced Hodgkin Lymphoma study2016 · 189 citations